Kbc Group Nv Neogenomics Inc Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Neogenomics Inc stock. As of the latest transaction made, Kbc Group Nv holds 6,557 shares of NEO stock, worth $37,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,557

Previous 6,557 -0.0%

Holding current value

$37,768

Previous $62,000 22.58%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$13.0 - $18.43 $26,351 - $37,357	2,027 Added 44.75%	6,557 $108,000
Q3 2024 Nov 06, 2024	BUY	$13.4 - $17.73 $15,101 - $19,981	1,127 Added 33.12%	4,530 $67,000
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $77,990 - $138,538	-6,683 Reduced 66.26%	3,403 $55,000
Q3 2023 Feb 15, 2024	SELL	$12.15 - $17.85 $76,411 - $112,258	-6,289 Reduced 62.35%	3,797 $47,000
Q2 2023 Feb 15, 2024	SELL	$14.1 - $19.83 $10,814 - $15,209	-767 Reduced 7.07%	10,086 $162,000
Q1 2023 Feb 14, 2024	SELL	$9.09 - $19.45 $6,972 - $14,918	-767 Reduced 7.07%	10,086 $176,000
Q1 2023 May 04, 2023	SELL	$9.09 - $19.45 $6,972 - $14,918	-767 Reduced 7.07%	10,086 $176,000
Q3 2022 Feb 15, 2024	BUY	$7.86 - $12.91 $58,557 - $96,179	7,450 Added 218.92%	10,853 $93,000
Q2 2022 Feb 14, 2024	BUY	$7.06 - $13.97 $52,597 - $104,076	7,450 Added 218.92%	10,853 $88,000
Q2 2022 Jul 26, 2022	BUY	$7.06 - $13.97 $76,622 - $151,616	10,853 New	10,853 $88,000
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $43,534 - $54,883	-1,045 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$36.08 - $56.47 $37,703 - $59,011	1,045 New	1,045 $56,000
Q4 2019 Feb 11, 2020	SELL	$18.96 - $29.84 $551,679 - $868,254	-29,097 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$12.14 - $20.46 $353,237 - $595,324	29,097 New	29,097 $0

Others Institutions Holding NEO

# of Institutions

283

Shares Held

126M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $725M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account